Overview

Evaluation of Adhesion Quality and Irritation of an Alternate Second Generation Estradiol Transdermal System

Status:
Completed
Trial end date:
2003-02-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study was to compare the adhesive quality of the current Mylan estradiol placebo transdermal system, with that of an alternate second generation Mylan estradiol placebo transdermal system following a single system application. As a secondary objective, primary dermal irritation was assessed after removal of each transdermal system.
Phase:
Phase 1
Details
Lead Sponsor:
Mylan Pharmaceuticals
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate